Bogaerts' break from lineup continues

Bogaerts' break from lineup continues

NEW YORK -- Red Sox shortstop Xander Bogaerts had his break from the starting lineup extended to three games on Sunday with the hope the extra day of treatment will help enliven his slumping bat when he returns to the lineup.

Bogaerts took a 92.1-mph fastball off the right hand from Rays right-hander Jacob Faria on July 6, but wound up missing just one game.

However, the injury has clearly hampered Bogaerts at the plate. In the 164 at-bats since then, Bogaerts is slashing .201/.276/.299 with two homers and 11 RBIs. He has also dealt with some other nagging injuries during that time.

Bogaerts could be back in there when the Red Sox open a homestand against the Blue Jays on Monday night.

"We felt like today was an additional day that he needed to get past some of the physical things he's dealing with, and by design, some downtime to hopefully collect himself and get back to the offensive player that he's been for a long time," said Red Sox manager John Farrell. "He's an important player for us. It's very important that we get him back on the field and back in the flow of things."

Eduardo Nunez once again played shortstop in place of Bogaerts.

Worth noting

• Left-hander David Price is expected to throw a 30-35-pitch bullpen session using all of his pitches on Monday at Fenway Park. If that goes well, Price could face hitters in the near future. In his attempted comeback from a left elbow injury, Price has started to build good momentum over the last week.

• The Red Sox made a couple of more September callups on Sunday, adding infielder Deven Marrero and righty Hector Velazquez. This is Marrero's fourth stint with the Red Sox this season. It is the fifth stint for Velazquez. Right-hander Carson Smith is expected to be activated on Monday to complete his comeback from the Tommy John surgery he underwent in May 2016.

Ian Browne has covered the Red Sox for MLB.com since 2002. Follow him on Twitter @IanMBrowne and Facebook. This story was not subject to the approval of Major League Baseball or its clubs.